| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.0B | $23.9B | $24.4B | $24.5B | $6.8B | $8.3B | $8.5B | $8.7B |
| Cost of Revenue | $13.7B | $14.1B | $15.3B | $15.0B | $4.5B | $5.3B | $5.3B | $5.4B |
| Gross Profit | — | — | — | — | — | — | — | $3.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $8.3B | $8.4B | $8.3B | $8.0B | $2.0B | $2.5B | $2.5B | $2.3B |
| Operating Income | $0.9B | $0.4B | $1.7B | $2.4B | $-4.5B | $1.0B | $1.7B | $1.8B |
| Net Income | $0.6B | $0.1B | $1.2B | $1.4B | $0.2B | $0.3B | $0.7B | $1.3B |
| EPS (Basic) | $2.10 | $0.38 | $4.28 | $4.66 | $0.51 | $1.10 | $2.40 | $4.34 |
| EPS (Diluted) | $2.07 | $0.38 | $4.19 | $4.55 | $0.50 | $1.09 | $2.37 | $4.31 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.4B | $16.2B | $16.9B | $17.6B | $17.7B | $21.2B | $19.2B | $19.4B |
| Current Assets | $6.5B | $6.1B | $5.9B | $6.8B | $6.2B | $6.8B | $7.4B | $7.4B |
| Cash & Equivalents | $1.3B | $1.0B | $0.9B | $1.7B | $1.7B | $0.7B | $1.2B | $1.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.5B | $4.4B | $4.9B | $5.4B | $5.4B | $5.8B | $5.2B | $5.1B |
| Stockholders' Equity | $4.6B | $4.1B | $4.1B | $3.6B | — | $6.4B | $6.4B | $5.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.3B | $1.6B | $2.7B | $0.6B | $1.6B | $1.7B | $1.9B |
| Investing Cash Flow | $-0.6B | $-0.9B | $-1.2B | $-0.4B | $-0.3B | $-1.0B | $-0.5B | $-0.4B |
| Capital Expenditures | $0.5B | $0.6B | $0.9B | $0.4B | $0.3B | $0.9B | $0.7B | $0.5B |
| Financing Cash Flow | $-0.4B | $-0.2B | $-1.3B | $-2.4B | $0.7B | $-1.1B | $-1.5B | $-1.4B |